HMGB1 and subarachnoid hemorrhage: Intervention using an anti-HMGB1 monoclonal antibody notably alleviated the severity of vasospasm and inhibited inflammatory responses within the arterial vascular wall subsequent to subarachnoid hemorrhage (SA).